5.055
Precedente Chiudi:
$4.74
Aprire:
$4.77
Volume 24 ore:
83,727
Relative Volume:
0.50
Capitalizzazione di mercato:
$182.48M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-2.5551
EPS:
-1.9784
Flusso di cassa netto:
-
1 W Prestazione:
+3.68%
1M Prestazione:
-11.21%
6M Prestazione:
+77.89%
1 anno Prestazione:
+0.00%
Anteris Technologies Global Corp Stock (AVR) Company Profile
Nome
Anteris Technologies Global Corp
Settore
Industria
Telefono
651-493-0606
Indirizzo
860 BLUE GENTIAN ROAD, EAGAN
Confronta AVR con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
AVR
Anteris Technologies Global Corp
|
5.06 | 164.81M | 0 | 0 | 0 | -1.9784 |
![]()
ISRG
Intuitive Surgical Inc
|
434.85 | 156.44B | 9.15B | 2.63B | 1.99B | 7.1661 |
![]()
BDX
Becton Dickinson Co
|
183.42 | 53.99B | 21.39B | 1.61B | 2.55B | 5.5609 |
![]()
RMD
Resmed Inc
|
270.14 | 39.41B | 5.15B | 1.40B | 1.65B | 9.5082 |
![]()
ALC
Alcon Inc
|
75.16 | 36.63B | 10.03B | 1.07B | 1.39B | 2.1549 |
![]()
WST
West Pharmaceutical Services Inc
|
265.83 | 18.78B | 2.96B | 487.70M | 344.00M | 6.6758 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-08 | Iniziato | Lake Street | Buy |
2025-01-07 | Iniziato | Barclays | Overweight |
2025-01-07 | Iniziato | Cantor Fitzgerald | Overweight |
2025-01-07 | Iniziato | TD Cowen | Buy |
Anteris Technologies Global Corp Borsa (AVR) Ultime notizie
Anteris secures first European green light to start PARADIGM pivotal trial of DurAVR THV - Proactive financial news
Anteris Technologies Secures European Clearance for Global PARADIGM Trial - TipRanks
Anteris Technologies Prepares for Annual Stockholder Meeting - TipRanks
Anteris Technologies Global schedules first annual meeting for December By Investing.com - Investing.com South Africa
Will Anteris Technologies Global Corp. stock outperform growth indexes2025 Investor Takeaways & Stock Portfolio Risk Management - newser.com
How strong is Anteris Technologies Global Corp. stock balance sheetQuarterly Market Review & Daily Profit Maximizing Trade Tips - newser.com
Will Anteris Technologies Global Corp. stock remain a Wall Street favoriteJuly 2025 Technicals & Fast Moving Trade Plans - newser.com
What does recent volatility data suggest for Anteris Technologies Global Corp.Weekly Risk Report & Community Consensus Trade Signals - newser.com
Combining machine learning predictions for Anteris Technologies Global Corp.Swing Trade & Risk Managed Investment Strategies - newser.com
How to monitor Anteris Technologies Global Corp. with trend dashboardsTrade Risk Summary & Risk Controlled Stock Pick Alerts - newser.com
Is Anteris Technologies Global Corp. trending in predictive chart modelsJuly 2025 Decliners & Verified Swing Trading Watchlists - newser.com
Will Anteris Technologies Global Corp. continue its uptrendJuly 2025 Breakouts & Reliable Trade Execution Plans - newser.com
Anteris Technologies Gains European Clearance for Heart Valve Trial - TipRanks
Anteris receives Danish approval for heart valve pivotal trial By Investing.com - Investing.com South Africa
Anteris Receives First European Regulatory Clearance To Commence DurAVR THV Global Pivotal Trial - TradingView
Anteris Receives First European Regulatory Clearance to - GlobeNewswire
Anteris Technologies Global Corp.’s volatility index tracking explained2025 Market Trends & Verified Entry Point Signals - newser.com
How hedge fund analytics apply to Anteris Technologies Global Corp. stock2025 Bull vs Bear & Expert-Curated Trade Recommendations - newser.com
How to interpret RSI for Anteris Technologies Global Corp. stockWatch List & Weekly Breakout Stock Alerts - newser.com
How rising interest rates impact Anteris Technologies Global Corp. stockWeekly Profit Summary & Weekly Momentum Picks - newser.com
Is this a good reentry point in Anteris Technologies Global Corp.2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - newser.com
How Anteris Technologies Global Corp. stock reacts to global recession fears2025 Volume Leaders & Weekly Stock Performance Updates - newser.com
What to expect from Anteris Technologies Global Corp. in the next 30 daysTrade Risk Assessment & Advanced Swing Trade Entry Plans - newser.com
Using data filters to optimize entry into Anteris Technologies Global Corp.July 2025 Gainers & Consistent Growth Equity Picks - newser.com
Investors bid Anteris Technologies Global (ASX:AVR) up AU$29m despite increasing losses YoY, taking five-year CAGR to 13% - simplywall.st
Anteris Technologies Global (NASDAQ:AVR) Earns Sell (E+) Rating from Weiss Ratings - MarketBeat
Tools to assess Anteris Technologies Global Corp.’s risk profileMarket Sentiment Summary & Fast Exit/Entry Strategy Plans - newser.com
Will Anteris Technologies Global Corp. price bounce be sustainableMarket Performance Report & Technical Pattern Recognition Alerts - newser.com
Reviewing Anteris Technologies Global (NASDAQ:AVR) and Helius Medical Technologies (NASDAQ:HSDT) - Defense World
Intraday pattern recognizer results for Anteris Technologies Global Corp.July 2025 Decliners & Capital Efficient Trade Techniques - newser.com
Is Anteris Technologies Global Corp. stock attractive for income investors2025 Market Sentiment & AI Forecast Swing Trade Picks - newser.com
Anteris Technologies Global Corp. stock prediction for this weekExit Point & Consistent Return Investment Signals - newser.com
Anteris Technologies Reports Changes in Securities Issuance - MSN
Anteris Technologies Says Patient Enrollment in Global Pivotal Registration Trial Expected to Begin in Q4 - 富途牛牛
Anteris Technologies Global Corp Azioni (AVR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Anteris Technologies Global Corp Azioni (AVR) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Paterson Wayne | Chief Executive Officer |
Mar 05 '25 |
Option Exercise |
7.13 |
233,000 |
1,661,290 |
233,000 |
Denaro Stephen | Director |
Mar 11 '25 |
Option Exercise |
7.13 |
16,500 |
117,645 |
23,722 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):